Literature DB >> 30089757

Carotid Intima-Media Thickness in Patients with Ankylosing Spondylitis: A Systematic Review and Updated Meta-Analysis.

Yaping Yuan1,2, Jiajia Yang1,2, Xu Zhang1,2, Renfang Han1,2, Mengya Chen1,2, Xingxing Hu1,2, Yubo Ma1,2, Meng Wu1,2, Mengmeng Wang1,2, Shengqian Xu3, Faming Pan1,2.   

Abstract

AIM: Inflammatory arthritis (IA) diseases are relevant with subclinical atherosclerosis, but the data in ankylosing spondylitis (AS) were inconsistent. Therefore, we performed this meta-analysis to explore the relationship between the marker of subclinical atherosclerosis (carotid intima-media thickness (IMT)) and AS.
METHODS: We performed a systematic literature review using PubMed, Web of Science, Chinese National Knowledge Infrastructure (CNKI) and Chinese Biomedical Database (CBM) databases up to March 2018. Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated to assess the association between carotid IMT and AS. Subgroup analysis, sensitivity analysis, and meta-regression were applied to explore the sources of heterogeneity, and publication bias was calculated to access the quality of pooled studies.
RESULTS: A total of 24 articles were collected. The carotid IMT was significantly increased in AS compared with healthy controls (SMD=0.725, 95% CI=0.443-1.008, p<0.001). Subgroup analyses showed the Bath Ankylosing Spondylitis Activity Index (BASDAI) was the source of heterogeneity. Notably, IMT was not significantly increased in those studies that included >50% patients treated with anti-TNF. Meta-regression revealed severe inflammation status (BASDAI and C-reactive protein (CRP)) could significantly impact carotid IMT in AS.
CONCLUSIONS: Carotid IMT was significantly increased in patients with AS compared with healthy controls, which suggested subclinical atherosclerosis is related to AS.

Entities:  

Keywords:  Ankylosing spondylitis; Atherosclerosis; Carotid intima-media thickness; Inflammation

Mesh:

Year:  2018        PMID: 30089757      PMCID: PMC6402883          DOI: 10.5551/jat.45294

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  6 in total

1.  Cardiovascular risk estimation in young patients with ankylosing spondylitis: A new model based on a prospective study in Constanta County, Romania.

Authors:  Mihaela Ionescu; Paris Ionescu; Adrian Paul Suceveanu; Anca Pantea Stoian; Ion Motofei; Valeriu Ardeleanu; Irinel-Raluca Parepa
Journal:  Exp Ther Med       Date:  2021-03-22       Impact factor: 2.447

2.  Endothelial dysfunction and increased carotid intima-media thickness in patients with spondyloarthritis without traditional cardiovascular risk factors.

Authors:  Aicha Ben Tekaya; Seif Boukriba; Ahmed Fendri; Leila Rouached; Olfa Saidane; Selma Bouden; Rawdha Tekaya; Kamel Ben Salem; Ines Mahmoud; Mizouni Habiba; Leila Abdelmoula
Journal:  RMD Open       Date:  2022-07

3.  Analysis of cardiovascular risk and carotid intima-media thickness in patients with psoriasis.

Authors:  Elaine Cristina Faria Abrahão-Machado; José Alexandre Mendonça; Ana Carolina Belini Bazán Arruda; Luciana Bertoldi Nucci; Marcel Alex Soares Dos Santos
Journal:  An Bras Dermatol       Date:  2020-01-31       Impact factor: 1.896

4.  Association between syndesmophyte and metabolic syndrome in patients with psoriatic arthritis or ankylosing spondylitis: a cross-sectional study.

Authors:  Chonachan Petcharat; Varalak Srinonprasert; Praveena Chiowchanwisawakit
Journal:  BMC Musculoskelet Disord       Date:  2021-04-20       Impact factor: 2.362

5.  High inflammatory burden predicts cardiovascular events in patients with axial spondyloarthritis: a long-term follow-up study.

Authors:  Lin-Hong Shi; Steven H Lam; Ho So; Edmund K Li; Tena K Li; Cheuk-Chun Szeto; Lai-Shan Tam
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-09-08       Impact factor: 3.625

6.  Subclinical atherosclerosis: A hidden threat for patients with ankylosing spondylitis.

Authors:  Wafa Hamdi; Kaouther Maatallah
Journal:  Anatol J Cardiol       Date:  2019-09       Impact factor: 1.596

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.